We confirmed the induction of LATS2 and YAP1 phosphorylation upon siRASAL2 treatment in a panel of CRC cell lines with or without KRAS/NRAS mutation (Fig. 5b). The gene discussed is NRAS; the disease is colorectal carcinoma.